ArticleOncotarget2017

Z-ligustilide restores tamoxifen sensitivity of ERa negative breast cancer cells by reversing MTA1/IFI16/HDACs complex mediated epigenetic repression of ERa.

Hui Ma et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.